Image of a neon sign with the word no lit up next to an unlit yes
Biotech

FDA rejects Regenxbio's Hunter syndrome gene therapy

After facing a delayed decision deadline and a clinical hold, Regenxbio’s Hunter syndrome gene therapy has been rejected by the FDA.
Darren Incorvaia Feb 9, 2026 4:05pm
Darts failing to hit bullseye

2025's top 10 clinical trial flops

Feb 9, 2026 3:00am
How AI Is reshaping clinical trials and market access

How AI Is reshaping clinical trials and market access

Feb 9, 2026 8:00am
Eli Lilly Lilly

Lilly buys Orna in $2.4B deal to enter in vivo CAR-T arena

Feb 9, 2026 8:41am
Article Primary Image 1jpg

The Data Multiplier Effect: The 4 Forces Changing Biometrics

Feb 9, 2026 8:00am
AI

BMS and Evinova pen global development partnership

Feb 9, 2026 2:33pm
More News

Fierce Biotech Fundraising Tracker '26: Angitia & more

Feb 9, 2026 9:00am

Takeda inks $1.7B AI discovery deal with Iambic Therapeutics

Feb 9, 2026 8:00am

Roche unveils data behind BTK inhibitor's phase 3 MS win

Feb 9, 2026 7:00am

Lilly, Innovent pen $8.8B collab 'beyond traditional licensing'

Feb 9, 2026 6:45am